These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 19332539)
1. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules. Komiyama T; Coppola JM; Larsen MJ; van Dort ME; Ross BD; Day R; Rehemtulla A; Fuller RS J Biol Chem; 2009 Jun; 284(23):15729-38. PubMed ID: 19332539 [TBL] [Abstract][Full Text] [Related]
2. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7. Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504 [TBL] [Abstract][Full Text] [Related]
3. The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases. Izaguirre G Viruses; 2019 Sep; 11(9):. PubMed ID: 31505793 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors. Tian S; Jianhua W Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049 [TBL] [Abstract][Full Text] [Related]
5. A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness. Coppola JM; Bhojani MS; Ross BD; Rehemtulla A Neoplasia; 2008 Apr; 10(4):363-70. PubMed ID: 18392131 [TBL] [Abstract][Full Text] [Related]
6. [Structure and properties of proprotein convertase inhibitors]. Kibirev VK; Osadchuk TV Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118 [TBL] [Abstract][Full Text] [Related]
7. Characterization and expression of proprotein convertases in CHO cells: Efficient proteolytic maturation of human bone morphogenetic protein-7. Sathyamurthy M; Kim CL; Bang YL; Kim YS; Jang JW; Lee GM Biotechnol Bioeng; 2015 Mar; 112(3):560-8. PubMed ID: 25219685 [TBL] [Abstract][Full Text] [Related]
8. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. Becker GL; Sielaff F; Than ME; Lindberg I; Routhier S; Day R; Lu Y; Garten W; Steinmetzer T J Med Chem; 2010 Feb; 53(3):1067-75. PubMed ID: 20038105 [TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum. Majumdar S; Mohanta BC; Chowdhury DR; Banik R; Dinda B; Basak A Curr Med Chem; 2010; 17(19):2049-58. PubMed ID: 20423311 [TBL] [Abstract][Full Text] [Related]
10. Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium. Freyer C; Kilpatrick LM; Salamonsen LA; Nie G Reproduction; 2007 Jun; 133(6):1189-97. PubMed ID: 17636173 [TBL] [Abstract][Full Text] [Related]
11. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. Becker GL; Lu Y; Hardes K; Strehlow B; Levesque C; Lindberg I; Sandvig K; Bakowsky U; Day R; Garten W; Steinmetzer T J Biol Chem; 2012 Jun; 287(26):21992-2003. PubMed ID: 22539349 [TBL] [Abstract][Full Text] [Related]
12. Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays. Ramos-Molina B; Lick AN; Blanco EH; Posada-Salgado JA; Martinez-Mayorga K; Johnson AT; Jiao GS; Lindberg I Biochem Pharmacol; 2015 Jul; 96(2):107-18. PubMed ID: 26003844 [TBL] [Abstract][Full Text] [Related]
13. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696 [TBL] [Abstract][Full Text] [Related]
15. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. Srour N; Lebel A; McMahon S; Fournier I; Fugère M; Day R; Dubois CM FEBS Lett; 2003 Nov; 554(3):275-83. PubMed ID: 14623079 [TBL] [Abstract][Full Text] [Related]
16. The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates. Mayer G; Hamelin J; Asselin MC; Pasquato A; Marcinkiewicz E; Tang M; Tabibzadeh S; Seidah NG J Biol Chem; 2008 Jan; 283(4):2373-84. PubMed ID: 18039650 [TBL] [Abstract][Full Text] [Related]
17. Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes. Sergeeva OA; van der Goot FG Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1279-1288. PubMed ID: 30610172 [TBL] [Abstract][Full Text] [Related]
18. The proprotein convertases furin and PACE4 play a significant role in tumor progression. Bassi DE; Mahloogi H; Klein-Szanto AJ Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462 [TBL] [Abstract][Full Text] [Related]
19. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread? Seidah NG; Pasquato A; Andréo U Viruses; 2021 Jun; 13(7):. PubMed ID: 34202098 [TBL] [Abstract][Full Text] [Related]
20. Thrombin activation of protein C requires prior processing by a liver proprotein convertase. Essalmani R; Susan-Resiga D; Guillemot J; Kim W; Sachan V; Awan Z; Chamberland A; Asselin MC; Ly K; Desjardins R; Day R; Prat A; Seidah NG J Biol Chem; 2017 Jun; 292(25):10564-10573. PubMed ID: 28468828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]